Accordingly, inhibition of VEGF production by tumor cells and the targeting of VEGFR2 and VEGFR2-mediated signaling pathways to prevent tumor-induced angiogenesis through the use of chemotherapeutic drugs have been considered effective approaches for cancer therapy [10,11,12]. This evidence concerns the gene KDR and cancer.